Familial restrictive cardiomyopathy
MONDO:0016340An instance of restrictive cardiomyopathy that is caused by an inherited modification of the individual's genome.
Also known as: hereditary restrictive cardiomyopathy
70 clinical trials for this condition and its sub-types, 0 tagged with Familial restrictive cardiomyopathy itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Familial restrictive cardiomyopathy
-
Glycogen storage disease II 31 trials · 41 incl. sub-types
-
Gaucher disease type I 12 trials
-
ATTRV122I amyloidosis 7 trials
-
Atrial standstill 1 trial
2 sub-types
- Atrial standstill 1 0 trials
- Atrial standstill 2 0 trials
-
1 sub-type
-
Dilated cardiomyopathy 1KK 0 trials
-
Can an oral pill ease breathing and muscle weakness in pompe disease?
Disease control Not yet recruitingThis early-stage trial is testing an experimental oral medication called S-606001 in adults with late-onset Pompe disease, a condition that causes progressive muscle weakness and breathing problems. The main goal is to see if the drug is safe and tolerable. Researchers will also …
Phase 1 • Sponsor: Shionogi • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can an oral pill boost muscle strength in pompe disease?
Disease control Not yet recruitingThis study tests the long-term safety and effectiveness of an experimental oral drug called S-606001 in adults with late-onset Pompe disease, a genetic condition that causes progressive muscle weakness. Participants who completed a prior S-606001 study can join, and they will rec…
Phase 2 • Sponsor: Shionogi • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC